MMMaggie Makar

Maggie Makar

*This is an algorithmically generated author record based on publicly available information.

Research Interests


Maggie Makar has a total of 3 co-authors. Here are the top co-authors by number of shared publications:

  • David M. Cutler

    Department of Economics, Kennedy School of Government, Harvard University, Cambridge, Massachusetts

    1 shared publication
  • Marzyeh Ghassemi

    Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, USA

    1 shared publication
  • Ziad Obermeyer

    From the Department of Emergency Medicine, Harvard Medical School and Brigham and Women's Hospital, and the Department of Health Care Policy, Harvard Medical School, Boston (Z.O.); and the Department of Medical Ethics and Health Policy, Perelman School of Medicine, and the Department of Health Care Management, Wharton School, University of Pennsylvania, Philadelphia (E.J.E.).

    1 shared publication

Latest Publications

  • Short-Term Mortality Prediction for Elderly Patients Using Medicare Claims Data

    by Maggie Makar, Marzyeh Ghassemi, David M. Cutler, Ziad Obermeyer

    Risk prediction is central to both clinical medicine and public health. While many machine learning models have been developed to predict mortality, they are rarely applied in the clinical literature, where classification tasks typically rely on logistic regression. One reason for this is that existing machine learning models often seek to optimize predictions by incorporating features that are not present in the databases readily available to providers and policy makers, limiting generalizability and implementation. Here we tested a number of machine learning classifiers for prediction of six-month mortality in a population of elderly Medicare beneficiaries, using an administrative claims database of the kind available to the majority of health care payers and providers. We show that machine learning classifiers substantially outperform current widely-used methods of risk prediction—but only when used with an improved feature set incorporating insights from clinical medicine, developed for this study. Our work has applications to supporting patient and provider decision making at the end of life, as well as population health-oriented efforts to identify patients at high risk of poor outcomes.